3rd Quarter - Report

CUBIST PHARMACEUTICALS, INC. for CUBIST PHARMACEUTICALS

Firm
Client
Income
—
Expenses
$290,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Changes to the US Patent System: H.R. 1249 / S.23, America Invents Act

LobbyistCovered position, as disclosed
MARK THOMAS BATTAGLINI —
GINETTE ELISE RHODES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 23 (112th), H.R. 1249 (112th)

Budget/Appropriations BUD

Medicare / Medicaid prescription medication reimbursement & FDA funding: FY 2012 Budget resolutions Affordable care act implementation: FY 2011/2012 appropriations for antibiotic resistance research. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012 Monitor Debt Ceiling Negotions: S.365 / Pub. L. 112-25, Budget Control Act of 2011 S/1599, Labor-HHS Appropriations

LobbyistCovered position, as disclosed
MARK THOMAS BATTAGLINI —
GINETTE ELISE RHODES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2608 (112th), S. 365 (112th), H.R. 2017 (112th)

Health Issues HCR

H.R. 3590 Implementing issues regarding General health care coverage and reimbursement. H.R. 6331 Patient Protection and Affordable Care Act H.R. 2182 - Generating Antibiotic Incentives Now (GAIN) Act Pub.L. 111-148 Patient Protection and Affordable Care Act of 2010 Pub. L. 111-152 Health cAre and Education Reconciliation Act of 2010 FDA legislation and regulatory implementation issues Issues pertaining to drug supply chain Antibiotic resistance issues Medical research

LobbyistCovered position, as disclosed
MARK THOMAS BATTAGLINI —
GINETTE ELISE RHODES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (112th), H.R. 2182 (112th), H.R. 6331 (112th)

Medicare/Medicaid MMM

H.R. 2195 / S.1203 Medicare Home Infusion Therapy Coverage Act of 2011 Prescription Drug Reimbursement: 340B issues S.365 / Pub. L. 112-25, The Budget Control Act and issues pertaining to sequestration and mandatory spending in federal programs. H.R. 2017 Continuing Appropriations Act, 2012 H.R. 2608 Continuing Appropriations Act, 2012 Pub. L. 111-148 Patient Protection and Affordable Care Act (implementation) Pub. L. 111-152 Health Care and Education Reconcilliation Act of 2010 (implementation)

LobbyistCovered position, as disclosed
MARK THOMAS BATTAGLINI —
GINETTE ELISE RHODES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1203 (112th), H.R. 2195 (112th), H.R. 2608 (112th), H.R. 2017 (112th), S. 365 (112th)

Pharmacy PHA

H.R. 2182 Generating Antibiotic Incentives Now (GAIN) Act of 2011 H.R. 2017 Continuing Appropriations Act, 2012 Pay-for-delay proposals and generic issues Antibiotic Resistance issues H.R. 2608 Continuing Appropriations Act, 2012 S. 365 / Pub. L. 112-25, Budget Control Act of 2011

LobbyistCovered position, as disclosed
MARK THOMAS BATTAGLINI —
GINETTE ELISE RHODES —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2017 (112th), H.R. 2608 (112th), S. 365 (112th), H.R. 2182 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.